Uppsala, Sweden, 15th July 2015 – Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the launch of Biotage® ACT (Anti Cross Talk) Plate Adapter, an innovative solution for prevention of well to well cross contamination during extract evaporation.
Biotage® ACT Plate Adapter is an essential accessory for evaporation devices. Constructed from robust, highgrade anodized aluminum, it fits on top of the 96-well collection plate containing the sample during evaporation. The plate adapter is compatible with straight needle evaporation devices such as the Biotage® SPE Dry 96 and Biotage® SPE Dry Dual systems, and does not require any changes to the existing analytical method.
The Biotage® ACT Plate Adapter is designed to fit on top of the 96-well collection plate, is reusable and easy to use. Evaporated gases are directed away from the sample wells, eddies are reduced, and the plate adapter reduces the open surface area of the top of the wells, lessening the likelihood that material can re-enter and contaminate adjacent wells.
“During evaporation a proportional amount of analytes present in an extracted sample can contaminate surrounding wells by being carried with the volatilized solvent. If the analyte concentration in one well is considerably higher than the analyte concentration in the surrounding wells it has the potential to cause a clinically significant and erroneous change to the adjacent samples. Biotage® ACT Plate Adapter is the first commercially available device to address the issue of cross talk on evaporation” says Dr. Claire Desbrow, Product Manager, Analytical Chemistry, Biotage.
The plate adapter can be incorporated into existing assays without the need for changing any other aspects of the method, and there is minimal impact of solvent drying times.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 3 5627 3123, other areas please call +46 18 56 57 10.
For further press information from Biotage please contact: James Churchill, Marketing Communications, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, Hengoed, Wales CF82 7TS United Kingdom, Tel: +44 (0)1443 811 849 Mobile: +44(0)7875484778 Email: firstname.lastname@example.org
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 293 employees with sales of 490 MSEK in 2014. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
TurboVap® in German
Biotage Acquires Horizon Technology
Extraction of Acidic Catecholamine Metabolites in Plasma Using ISOLUTE® SLE+ Prior to LC-MS/MS Analysis
Video Demonstration: Multi Racks for TurboVap®
Effective Purification of Peptides using Normal Phase Flash